[Stress crisis caused by tumor degradation products following multiple stage cancer therapy and its control by increasing the alpha 2-globulin fractions].
D000510:Alpha-Globulins / Q000032:analysis*; D000818:Animals; D001500:BCG Vaccine; D003520:Cyclophosphamide / Q000627:therapeutic use*; D004195:Disease Models, Animal; D008259:Macroglobulins / Q000032:analysis*; D009374:Neoplasms, Experimental / Q000097:blood / Q000139:chemically induced / Q000401:mortality / Q000532:radiotherapy / Q000628:therapy*; D009602:Nitrosamines; D051381:Rats; D013268:Stimulation, Chemical; D013312:Stress, Physiological / Q000517:prevention & control*; D013997:Time Factors; D005719:gamma-Globulins / Q000097:blood / Q000627:therapeutic use*
D000510:Alpha-Globulins; D001500:BCG Vaccine; D008259:Macroglobulins; D009602:Nitrosamines; D005719:gamma-Globulins; D003520:Cyclophosphamide
Die Belastungskrise durch Tumorabbauprodukte nach Krebs-Mehrschritt-Therapie und ihre Minderung durch Erhöhung der   2 -Globulinfraktion.